ArticleBMC neurology2023

High-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study.

Alain Créange et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.